Biological E. Limited (BE) to Manufacture Up to 50 Million Doses of QDENGA Per Year, Accelerating Takeda’s Ability to Deliver 100 Million Doses Per Year by 2030 At the Latest Addresses the Specific Need to Offer Multi-Dose Vials for National Immunization Programs to
AINU Secunderabad Restores Normalcy after Improper Antibiotic Use Sparks Crisis In a cautionary tale, patient father's GOOD WILL to treat his daughter's illness using internet knowledge led to a serious health crisis. Incomplete antibiotic courses resulted in a severe kidney infection and the formation of stone-like
QAI becomes the 1st Indian Accreditation Body and one of the 15 such ABs globally to be recognised by the American Regulator, United States Environmental Protection Agency (USEPA) as EPA Toxic Substances Control Act Title VI Laboratory Accreditation Body (EPA TSCA Title VI Laboratory AB) under EPA TSCA Title
Partnership to focus on advanced molecular diagnostic solutions for key health challenges including diabetic foot infection – reducing risk of serious complications Mylab Discovery Solutions, India’s leading biotech company, and DnaNudge, a UK-based pioneer of consumer genetics testing and medical diagnostics, today announced a
